FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

766128003: Product containing precisely galactose 2.49 gram and palmitic acid 2.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3689702014 Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3689703016 Product containing precisely galactose 2.49 gram and palmitic acid 2.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3689701019 Product containing precisely galactose 2.49 gram and palmitic acid 2.5 milligram/1 vial powder for conventional release suspension for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3689702014 Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3689703016 Product containing precisely galactose 2.49 gram and palmitic acid 2.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Is a Product manufactured as parenteral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Has manufactured dose form Powder for conventional release suspension for injection (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Has presentation strength denominator unit (attribute) Vial (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Is a Product containing galactose and palmitic acid (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Has unit of presentation Vial (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Count of base of active ingredient deux false Inferred relationship Existential restriction modifier (core metadata concept)
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Has presentation strength denominator unit (attribute) Vial (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Has presentation strength numerator unit (attribute) g true Inferred relationship Existential restriction modifier (core metadata concept) 1
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Has basis of strength substance (attribute) Palmitic acid true Inferred relationship Existential restriction modifier (core metadata concept) 2
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Has precise active ingredient Palmitic acid true Inferred relationship Existential restriction modifier (core metadata concept) 2
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Has basis of strength substance (attribute) Galactose (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Has presentation strength numerator value 2.5 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Has precise active ingredient Galactose (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Has presentation strength numerator value 2.49 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Is a Product containing only galactose and palmitic acid in parenteral dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start